Diagnostic Criteria

COL4A1-related disorders cover a spectrum of overlapping phenotypes characterized by a small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (congenital cataract, retinal arterial tortuosity, eye anterior segment anomaly of Axenfeld-Rieger type) and systemic findings (muscle cramps and/or serum creatine kinase (CK) elevation, kidney involvement, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia).

Suggestive Findings

A COL4A1-related disorder should be suspected in individuals with any of the following phenotypes, which have overlapping features:

Source: GeneReviews — "COL4A1-Related Disorders"

Differential Diagnosis

COL4A2-related porencephaly and intracerebral hemorrhages. Seven heterozygous COL4A2 pathogenic variants have been characterized in individuals with either porencephaly (porencephaly type 2; OMIM 614483) or intracerebral hemorrhage (OMIM 614519). Neurologic presentation of individuals with porencephaly type 2 was similar to that observed in COL4A1-related porencephaly . Four patients presented with adult-onset intracerebral hemorrhage . Variably present extracerebral symptoms included cerebellar and optic atrophy, cataracts, intracranial aneurysms, nephropathy, and myopathy .

Source: GeneReviews — "COL4A1-Related Disorders"

Management Guidelines

Evaluations Following Initial Diagnosis

To establish the extent of disease and needs in an individual diagnosed with COL4A1-related disorders, the following are recommended:

• Brain MRI including T1-weighted saggital, T2-weighted axial, and FLAIR axial images

• Brain angiographic CT scan

• Ophthalmologic examination including fundoscopic examination and slit-lamp examination

• Kidney and liver ultrasound examination or CT

• Measurement of serum CK concentration

• Measurement of serum creatinine concentration and estimation of the glomerular filtration rate

• Evaluation for the presence of hematuria

• Electrocardiogram (EKG); echocardiography and ambulatory EKG monitoring in individuals presenting with palpitations

• Consultation with a clinical geneticist and/or genetic counselor

Treatment of Manifestations

Hypertensive individuals must be treated to reduce the global risk of stroke. Supportive care including practical help, emotional support, and counseling are appropriate for affected individuals and their families. No specific support exists for individuals with COL4A1-related disorders.

Clinical Guidance

The following should be avoided:

• Smoking because it increases the global risk of stroke

• Hypertension because it increases the risk of stroke

• Sustained head pressure during birth or postnatal physical activities that may cause head trauma

• Anticoagulant use

Source: GeneReviews — "COL4A1-Related Disorders"

Therapies Under Investigation

Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.

Source: GeneReviews — "COL4A1-Related Disorders"

Surveillance Guidelines

The interval at which individuals with COL4A1-related disorders should be seen for follow up depends on the severity and type of symptoms. Annual clinical evaluation is reasonable. Regular brain imaging can be proposed, especially to evaluate the size of asymptomatic cerebral aneurysms.

Source: GeneReviews — "COL4A1-Related Disorders"